Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Ruco

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|September 18, 2008
Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphomaMaria Christina Cox, Italo Nofroni, Luigi Ruco, et al.
Journal of Cellular Physiology|June 18, 2015
Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung CancerEmanuela Cherubini, Arianna Di Napoli, Alessia Noto, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2017
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapySimone Battella, M Christina Cox, Raffaella La Scaleia, et al.
Human Pathology|February 24, 2015
Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderlyStefania Uccini, Mazin F Al-Jadiry, Stefania Scarpino, et al.
Future Oncology (London, England)|October 4, 2012
Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practiceLuigi Rossi, Enzo Veltri, Angelo Zullo, et al.
Pediatric Blood & Cancer|September 13, 2018
Burkitt lymphoma in Iraqi children: A distinctive form of sporadic disease with high incidence of EBVStefania Uccini, Mazin F Al-Jadiry, Claudia Cippitelli, et al.
Oncotargets and Therapy|December 19, 2013
Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutationLuigi Rossi, Enzo Veltri, Angelo Zullo, et al.
Oncoimmunology|May 8, 2015
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patientsM Christina Cox, Simone Battella, Raffaella La Scaleia, et al.
The American Journal of Pathology|March 26, 2003
Transglutaminase type II plays a protective role in hepatic injuryRoberta Nardacci, Oreste Lo Iacono, Fabiola Ciccosanti, et al.
Oncotarget|July 31, 2013
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancerAlessia Noto, Claudia De Vitis, Giuseppe Roscilli, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|September 18, 2008
Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphomaMaria Christina Cox, Italo Nofroni, Luigi Ruco, et al.
Journal of Cellular Physiology|June 18, 2015
Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung CancerEmanuela Cherubini, Arianna Di Napoli, Alessia Noto, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2017
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapySimone Battella, M Christina Cox, Raffaella La Scaleia, et al.
Human Pathology|February 24, 2015
Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderlyStefania Uccini, Mazin F Al-Jadiry, Stefania Scarpino, et al.
Future Oncology (London, England)|October 4, 2012
Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practiceLuigi Rossi, Enzo Veltri, Angelo Zullo, et al.
Pediatric Blood & Cancer|September 13, 2018
Burkitt lymphoma in Iraqi children: A distinctive form of sporadic disease with high incidence of EBVStefania Uccini, Mazin F Al-Jadiry, Claudia Cippitelli, et al.
Oncotargets and Therapy|December 19, 2013
Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutationLuigi Rossi, Enzo Veltri, Angelo Zullo, et al.
Oncoimmunology|May 8, 2015
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patientsM Christina Cox, Simone Battella, Raffaella La Scaleia, et al.
The American Journal of Pathology|March 26, 2003
Transglutaminase type II plays a protective role in hepatic injuryRoberta Nardacci, Oreste Lo Iacono, Fabiola Ciccosanti, et al.
Oncotarget|July 31, 2013
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancerAlessia Noto, Claudia De Vitis, Giuseppe Roscilli, et al.
Pageof 5